Status:
COMPLETED
Treatment of BV With Donaxyl and a Molecular Test of Cure
Lead Sponsor:
Skaraborg Hospital
Conditions:
Bacterial Vaginoses
Eligibility:
FEMALE
18-45 years
Brief Summary
. Treatment with dequalinium chloride vaginal tablets for 6 days had a cure rate lower than expected; only 37% of patients were considered cured one month after treatment.
Detailed Description
This is the first study to utilize a molecular diagnostic test as a test of cure for bacterial vaginosis. The Nugent score is a reliable method for diagnosing bacterial vaginosis, but similar to tradi...
Eligibility Criteria
Inclusion
- BV
Exclusion
- No other infection (Gc, clhlamydia, trihomonas)
Key Trial Info
Start Date :
May 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2018
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT04057482
Start Date
May 1 2015
End Date
April 1 2018
Last Update
August 15 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.